People in almost any business must write from time to time, whether they like it or not. But whatever the project — like a marketer’s blog post, a business leader’s executive summary or a developer’s ...
MADISON, Wis., Jan. 8, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, ...
MADISON, Wis., April 16, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed the elive™ ex vivo tumor profiling platform, announced a scientific ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Madison-based Elephas Biosciences Corp. announced Tuesday the ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Elephas is developing an oncology diagnostics platform that ...
Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Madison-based cancer diagnostics ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Madison-based cancer ...
A phase 1 first-in-human study of the novel anti-LLT1 antibody (ZM008) alone and in combination with anti-PD1 antibody in patients with advanced solid tumors. Phase II basket study to evaluate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results